Loteprednol vs Prednisolone to Treat Intraocular Inflammation Following Cataract Surgery in Children
December 6, 2011
Bausch & Lomb, Inc. is getting ready to launch a study that will evaluate the efficacy and safety of topical Loteprednol Etabonate (LE), 0.5%, to Prednisolone Acetate 1%, for the treatment of postoperative inflammation following ocular surgery for childhood cataract.
Children up to 11 years old who are candidates for routine, uncomplicated surgery for childhood cataract are eligible, subject to certain exclusion criteria.
Click here for further details.
Jump down to form below to submit your own comments